research & Development

Nuclear Theranostic Drugs

Peptide receptor imaging technology (PRIT) can be used for peptide receptor radionuclide diagnosis and therapy (PRRT). The principle is as follows: target is called “Lock” (referring to tumor cells), and its tissue is characterized by highly expressed receptors on the surface; Ligand is called “Key” (referring to somatostatin analogues), such as octreotide…



Platform : Targeted Molecular Imaging & Radionuclide Therapy